bupropion
- Product NDC
- 68788-7249
- 11-digit product format
- 687887249
- Labeler code
- 68788
- Product ID
- 68788-7249_f6f3ed27-aa48-4fb1-b4c0-9704aba7e724
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2018-08-27
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7249-1 | 68788724901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-1) | 2018-08-27 | 0000-00-00 | No | No | Current |
| 68788-7249-2 | 68788724902 | 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-2) | 2018-08-27 | 0000-00-00 | No | No | Current |
| 68788-7249-3 | 68788724903 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-3) | 2018-08-27 | 0000-00-00 | No | No | Current |
| 68788-7249-6 | 68788724906 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-6) | 2018-08-27 | 0000-00-00 | No | No | Current |
| 68788-7249-8 | 68788724908 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-8) | 2018-08-27 | 0000-00-00 | No | No | Current |
| 68788-7249-9 | 68788724909 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7249-9) | 2018-08-27 | 0000-00-00 | No | No | Current |